We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
Cap. Flow
-$21B
Cap. Flow %
-11.12%
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Healthcare 11.06%
3 Financials 8.17%
4 Consumer Discretionary 8.09%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQR icon
526
Equity Residential
EQR
$24.9B
$69M 0.04%
889,335
-48,971
-5% -$3.7M
NOW icon
527
PUT
ServiceNow
NOW
$115B
$68.8M 0.04%
616,000
-134,000
-18% -$13.6M
BX icon
528
PUT
Blackstone
BX
$102B
$68.6M 0.04%
693,600
+506,300
+270% +$45M
IFF icon
529
International Flavors & Fragrances
IFF
$20.2B
$68.5M 0.04%
460,588
+113,923
+33% +$16.3M
VZ icon
530
CALL
Verizon
VZ
$195B
$68.3M 0.04%
1,223,500
+216,100
+21% +$12.4M
UPWK icon
531
Upwork
UPWK
$1.13B
$68.2M 0.04%
1,169,948
-77,861
-6% -$3.66M
PSX icon
532
Phillips 66
PSX
$84.9B
$67.8M 0.04%
796,127
-93,511
-11% -$7.89M
GNRC icon
533
Generac Holdings
GNRC
$11.6B
$67.7M 0.04%
165,046
+36,092
+28% +$12.1M
XLNX
534
DELISTED
Xilinx Inc
XLNX
$67.7M 0.04%
467,942
-167,887
-26% -$21.3M
IYR icon
535
iShares US Real Estate ETF
IYR
$4.66B
$67.7M 0.04%
663,920
+130,416
+24% +$12.9M
TPTX
536
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$67.3M 0.04%
862,398
+53,636
+7% +$3.96M
CNC icon
537
Centene
CNC
$30.7B
$67.1M 0.04%
910,124
-35,433
-4% -$2.43M
DD icon
538
DuPont de Nemours
DD
$18.5B
$67.1M 0.04%
693,288
-110,189
-14% -$11.1M
FE icon
539
FirstEnergy
FE
$28B
$67.1M 0.04%
1,787,570
+935,213
+110% +$34.8M
DHI icon
540
D.R. Horton
DHI
$40B
$66.9M 0.04%
739,660
-24,835
-3% -$2.33M
WBA
541
DELISTED
Walgreens Boots Alliance
WBA
$66.9M 0.04%
1,271,545
+72,410
+6% +$3.9M
BAX icon
542
Baxter International
BAX
$13.5B
$66.6M 0.04%
813,788
+117,580
+17% +$9.86M
MFC icon
543
Manulife Financial
MFC
$73.9B
$66.4M 0.04%
3,370,030
-487,271
-13% -$10.2M
WORK
544
DELISTED
Slack Technologies, Inc.
WORK
$66.4M 0.04%
1,484,073
-141,944
-9% -$6.08M
GD icon
545
General Dynamics
GD
$104B
$66.2M 0.04%
354,585
+16,392
+5% +$3.09M
TMO icon
546
PUT
Thermo Fisher Scientific
TMO
$213B
$66.1M 0.04%
130,000
-64,600
-33% -$30.5M
IBM icon
547
PUT
IBM
IBM
$211B
$66M 0.04%
474,466
-26,254
-5% -$3.59M
KHC icon
548
Kraft Heinz
KHC
$30.7B
$65.7M 0.03%
1,611,753
-812,909
-34% -$34.2M
PPG icon
549
PPG Industries
PPG
$24.6B
$65.7M 0.03%
389,485
-47,410
-11% -$8.13M
ARKK icon
550
PUT
ARK Innovation ETF
ARKK
$5.64B
$65.5M 0.03%
501,200
-346,500
-41% -$40.4M

Similar funds

Credit Suisse's Q2 2021 Portfolio in Review

As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.

  • Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
  • Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
  • Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
  • Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
  • Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
  • Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
  • Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.